Skip to main content

Antibe Therapeutics Inc(ATE-T)
TSX

Today's Change
Real-Time Last Update
Volume
Day Low0.58
Day High0.62
Open:0.58
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

StockReports+

A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.

Download Premium PDFRefinitiv. Trademark. Data is Just the Beginning.

StockCalc

What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.

Download Premium PDFStockCalc

ValuEngine

A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.

Download Premium PDFValueEngine

Press & news

Latest News

More Stories
Antibe Therapeutics: Top 10 Undervalued Nano Cap Stocks on TSX (ATE)
The Globe and Mail - Sat Feb 4, 10:05AM CST
The Globe and Mail
Sat Feb 4, 10:05AM CST
Antibe Therapeutics is now ranked among the top 10 nano cap stocks on the Toronto Stock Exchange. A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a...
Antibe Therapeutics: Stocks trading at Less Than Cash Value on TSX (ATE)
The Globe and Mail - Sun Jan 29, 10:04AM CST
The Globe and Mail
Sun Jan 29, 10:04AM CST
Antibe Therapeutics is among the group of Toronto Stock Exchange companies currently trading at less than cash value. This means companies whose current share price is less than the cash per share on their balance sheet or stocks with more cash...
Antibe Therapeutics: Top 10 Undervalued Medical Devices & Instruments Industry Stocks (ATE)
The Globe and Mail - Mon Jan 23, 10:07AM CST
The Globe and Mail
Mon Jan 23, 10:07AM CST
Antibe Therapeutics is now ranked among the top 10 undervalued stocks in the Medical Devices & Instruments industry on the Toronto Stock Exchange or TSX Venture Exchange. A stock is considered undervalued if it trades at a discount to its...

Latest Articles

Friday’s analyst upgrades and downgrades
Monday’s analyst upgrades and downgrades
Wednesday’s analyst upgrades and downgrades
Friday’s analyst upgrades and downgrades
Thursday’s analyst upgrades and downgrades
Market movers: Stocks that saw action on Tuesday - and why
Wednesday’s analyst upgrades and downgrades

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2023.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2023 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.